Alphabet, Goodyear, Liberty Global and Deutsche Telekom all took part in a round hiking the crypto IoT network developer’s valuation to $1.2bn
Author: Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the Global Venturing Review podcast.
Modern Treasury magnifies series C to $135m
Salesforce Ventures helped top up the business payment platform developer’s series C round with a $50m extension.
Chief orders up $100m
Alphabet unit CapitalG led the female executive network’s series B round at a valuation of $1.1bn and is taking a board seat.
LayerZero Labs stacks up $135m
FTX Ventures, Uniswap, Coinbase Ventures and PayPal Ventures helped boost the blockchain technology developer’s valuation to $1bn.
Brightline shines on $105m series C
GV, Optum, Children’s Medical Center Corporation and Blue Cross Blue Shield of Massachusetts returned to take the behavioural health provider’s overall funding past $200m.
SoftBank spearheads $100m Neuron23 round
The neurological disease treatment developer took its funding to over $213m, completing a series C round led by SoftBank Vision Fund 2.
LetsGetChecked to buy Veritas Genetics
LetsGetChecked is moving into genomics with the acquisition of the genetic testing technology provider, allowing Lilly Ventures Asia and Jiangsu Simcere to exit.
Synspective focuses on $100m series B
Sompo Japan led a round which doubled the satellite developer’s overall funding to $200m and which is set to support its expansion plans.
Yokoy locates $80m in series B round
Swisscom and Six came back to participate in the expense management platform developer’s latest round, lifting its total funding to approximately $108m.
Haegin hails corporates in series B round
Kakao, NetEase, VNG and Netmarble all backed the mobile game developer as it looks to grow its metaverse capabilities and release new titles.
Liberty Strategic Capital to buy Zimperium for $525m
SoftBank will retain a minority stake in the cybersecurity technology provider, as Telstra, Toyo Corporation and Samsung prepare to exit.
Zongmu drives through $157m series A
Cosco Shipping Development was among the investors in a round set to boost the self-driving technology developer’s research and development activities.
AN2 Therapeutics prices $69m IPO
The Brii Biosciences-backed lung disease treatment developer priced an upsized offering in the middle of its range.
WeRide zooms to $400m
GAC and Bosch were reportedly among the investors which put up fresh capital for the autonomous driving technology developer at a $4.4bn valuation.